SpassMed Receives US FDA 510(k) for AI Sepsis Detection Software
South Korean medical AI company SpassMed has received 510(k) clearance from the US Food and Drug Administration for its AI-powered sepsis detection software.
The AI solution called SpassageQ has been approved as software as a medical device to detect sepsis, anaphylaxis and hypovolemic shock.
South Korean researchers use AI to predict side effects of immunotherapy
Researchers from various South Korean universities have teamed up to develop an AI model to predict the side effects of immunotherapy in cancer patients.
The Korea Advanced Institute of Science and Technology and Asan Medical Center first compiled a comprehensive list of risk factors for side effects of immuno-oncology drugs based on patients’ genomes, transcriptomes and blood indicators. This was extracted from a large prospective cohort of solid cancer patients in collaboration with nine South Korean medical institutions.
From this, a deep learning prediction model was developed that determines whether a patient will show side effects of an immunotherapy before receiving it.
The research was conducted against the background of a lack of understanding of such side effects, which have been shown to resemble autoimmune diseases and, in the worst cases, can even lead to death.
Fujifilm India launches mobile app for vendors
Fujifilm India has launched a mobile app that healthcare providers can use to manage the service and support for their medical diagnostic equipment.
Available on iOS and Android phones, Fujifilm Connect allows service request submission and tracking, maintenance record viewing and device performance monitoring. It also has features that help with customer support such as: B. a 24/7 call logging process and real-time visibility of contract status.
KT Corp. develops a Vietnamese medical information platform with Dong-A ST
South Korean telecom giant KT Corporation is collaborating with Dong-A ST, a pharmaceutical company in Vietnam, to create a Vietnamese-language medical information platform.
The goal of the partnership is to create content about South Korean medical technology for Vietnamese medical workers. According to a media release, the platform will be released in July.
TatvaCare launches COPD DTx clinical trial
Indian health technology company TatvaCare is launching a clinical trial of its MyTatva digital therapy solution for people with chronic respiratory diseases.
The MyTatva digital-based solution combines personalized care plans, IoT device monitoring, coaching and consulting services to improve patient compliance with their care program.
According to a press release, the BREATHE DTx study aims to test the effectiveness and acceptability of DTx in COPD and asthma. It will also assess its ability to reduce exacerbations and incidents.
It will be held at eight facilities in India for six months and will involve up to 200 participants.
